Global fund managers raised their allocation to equities by the largest amount on record in May, supported by optimism surrounding corporate earnings growth and expectations that the Federal Reserve could begin cutting interest rates, according to Bank of America’s monthly survey released on Tuesday. The survey showed that investor sentiment toward equities improved significantly even… Continue reading Equity allocations surge as investors bet on earnings and lower rates
stocktrader
Standard Chartered to cut over 7,000 jobs as AI expands
London-headquartered Standard Chartered plans to cut more than 7,000 jobs over the next four years as the lender increases the use of artificial intelligence while pursuing higher profitability and operational efficiency. The bank said on Tuesday it would reduce 15% of its corporate function roles by 2030. The lender’s total global workforce stands at nearly… Continue reading Standard Chartered to cut over 7,000 jobs as AI expands
Kuark bets big on Asia AI boom with $400 million hedge fund
Kuark Capital, a Hong Kong-based investment firm led by Taiwanese investor Kyle Su, has raised at least $400 million ahead of the launch of a new hedge fund focused on artificial intelligence-related investments in Asia. The fund will target opportunities in Taiwan and Japan and adopt a low-net equity long-short strategy designed to limit overall… Continue reading Kuark bets big on Asia AI boom with $400 million hedge fund
Kospi Index slips as South Korean bond yields jump: buy the dip?
The Kospi Index retreated into a correction as the recent rally takes a breather amid overheating concerns. It retreated to KRW 7,250, down by 10% from the year-to-date high of KRW 8,038. It remains up by over 72% this year and 178% in the last 12 months. So, is this the end of the Kospi… Continue reading Kospi Index slips as South Korean bond yields jump: buy the dip?
Nifty 50 Index at risk as Indian bond yields surge, rupee crash
Indian stocks are stuck in a correction this week as concerns about the economy remain. The blue-chip Nifty 50 Index retreated to ₹23,650 on Tuesday, down by 10% from its highest point this year. This retreat has coincided with the crashing Indian rupee and bonds. Indian stocks retreat amid US-Iran war concerns The Nifty 50… Continue reading Nifty 50 Index at risk as Indian bond yields surge, rupee crash
Dan Loeb reveals a stake in a semiconductor ETF: find out more
Billionaire Dan Loeb’s flagship hedge fund, Third Point, recalibrated its portfolio in the first quarter of 2026, leaning heavily into the AI trade by initiating a new position in the Vaneck Semiconductor ETF (SMH). Loeb simultaneously increased exposure to individual chip-equipment makers – including ASML, Lam Research, and KLA Corp. Other notable investments he made… Continue reading Dan Loeb reveals a stake in a semiconductor ETF: find out more
Dow rises while Nasdaq slides on oil surge, Treasury yields pressure tech
US stocks ended mixed on Monday as investors monitored rising oil prices, elevated Treasury yields, and escalating tensions in the Middle East, while technology stocks extended their recent pullback after a record-setting rally earlier this month. The Dow Jones Industrial Average rose 159.95 points, or 0.32%, to close at 49,686.12. Meanwhile, the S&P 500 slipped… Continue reading Dow rises while Nasdaq slides on oil surge, Treasury yields pressure tech
Seagate stock slides 7% as AI demand sparks capacity fears
Shares of Seagate Technology (STX) fell sharply on Monday after comments from CEO Dave Mosley raised investor concerns that the company may struggle to keep pace with surging artificial-intelligence-related demand for data storage solutions. Seagate shares dropped roughly 7% during trading after Mosley discussed the company’s manufacturing strategy at the JPMorgan Global Technology, Media and… Continue reading Seagate stock slides 7% as AI demand sparks capacity fears
Regeneron stock drops double digits on oncology trial failure
Shares of Regeneron Pharmaceuticals (REGN) fell about 12% on Monday, making the biotech company the worst-performing stock in the S&P 500 after its experimental melanoma treatment failed a pivotal late-stage clinical trial. The sharp selloff followed Regeneron’s announcement that its high-dose fianlimab and cemiplimab combination failed to significantly outperform Merck’s Keytruda in a Phase 3… Continue reading Regeneron stock drops double digits on oncology trial failure